peculation in recent months has centered on how GLP-1 agonists such as Ozempic, Trulicity and Mounjaro may impact food and beverage demand. From a product development perspective, the medications may turn consumer attention to satiety and how ingredients like fiber, protein and the sweetener allulose may keep consumers, Read more